Uniqure

Uniqure EBITDA per Share

The EBITDA per Share of Uniqure (QURE) as of Nov 16, 2026 is -3.27 USD. In the previous year, EBITDA per Share was -3.77 USD — a change of -13.43% (higher).

EBITDA per Share

-3.27USD

YoY

-13.43%

Last updated:

EBITDA per Share of Uniqure is 2025 -3.27 USD. EBITDA per Share of Uniqure was 2024 -3.77 USD. It decreases by -13.43% higher compared to the previous year.

The Uniqure EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-2.46 USD
Jan 1, 2019
-3.01 USD
Jan 1, 2020
-2.82 USD
Jan 1, 2021
6.63 USD
Jan 1, 2022
-3.05 USD
Jan 1, 2023
-5.91 USD
Jan 1, 2024
-3.77 USD
Jan 1, 2025
-3.27 USD
The Uniqure EBITDA per Share history
YEAREBITDA per ShareYoY
-3.27USD-13.43%
-3.77USD-36.19%
-5.91USD+94.02%
-3.05USD-145.96%
6.63USD-335.10%
-2.82USD-6.40%
-3.01USD+22.56%
-2.46USD-6.49%
-2.63USD-7.72%
-2.85USD-15.30%
-3.36USD+42.07%
-2.37USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Uniqure Stock analysis

What does Uniqure do? Uniqure NV is a Dutch biotechnology company specializing in the development of gene therapies for rare diseases. The company was founded in 1999 and is headquartered in Amsterdam. Uniqure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniqure stock

EBITDA per Share of Uniqure is -3.27 USD in 2025.

EBITDA per Share of Uniqure changed from -3.77 USD to -3.27 USD, representing a -13.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Uniqure since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Uniqure

All Key Metrics — Uniqure